A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study

Human Genetics

Volumn 111, Issue 3, 2002, Pages 263-269

  Coon, Hilary ^a   Eckfeldt, John H ^b   Leppert, Mark F ^a   Myers, Richard H ^c   Arnett, Donna K ^d   Heiss, Gerardo ^e   Province, Michael A ^f   Hunt, Steven C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e IL   (United States)

^f WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ESTROGEN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOLISM; ARTICLE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 11; CHROMOSOME 5; DIABETES MELLITUS; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HIP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LABORATORY; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING;

CHOLESTEROL, LDL; CHROMOSOMES, HUMAN, PAIR 11; CORONARY DISEASE; FEMALE; GENETIC MARKERS; GENETIC SCREENING; GENOME, HUMAN; HUMANS; LOD SCORE; MALE; MIDDLE AGED; RISK FACTORS; VARIATION (GENETICS);

MAMMALIA;

EID: 0036765576     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0773-8     Document Type: Article

References (49)

1. Aouizerat BE, Allayee H, Cantor RM, Davis RC, Lanning CD, Wen PZ, Dallinga-Thie GM, De Bruin TW, Rotter JI, Lusis AJ (1999) A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am J Hum Genet 65:397-412
2. Austin MA, King MC, Bawol RD, Hulley SB, Friedman GC (1987) Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol 125:308-318
3. Battaile KP, Steiner RD (2000) Smith-Lemli-Opitz syndrome: The first malformation syndrome associated with defective cholesterol synthesis. Mol Genet Metab 71:154-162
4. Breslow J (1988) Apolipoprotein genetic variation and human disease. Physiol Rev 68:85-132
5. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL (1998) Comprehensive human genetic maps: Individual and sex-specific variation in recombination. Am J Hum Genet 63:861-869
6. Castelli WP, Doyle JP, Gordon T (1977) HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study. Circulation 55:767-772
7. Cherry JL, Young H, Di Sera LJ, Ferguson FM, Kimball AW, Dunn DM, Gesteland RF, Weiss RB (1994) Enzyme-linked fluorescent detection for automated multiplex DNA sequencing. Genomics 20:68-74
8. Ciccarese M, Pacifico A, Tonolo G, Pintus P, Nikoshkov A, Zuiani G, Fellin R, Luthman H, Maioli M (2000) A new locus for autosomal recessive hypercholesterolemia maps to human chromosome 15q25-26. Am J Hum Genet 66:453-460
9. Coon H, Leppert MF, Province MA, Myers RH, Arnett DK, Heiss G, Williams RR, Hunt SC (1999) Evidence for a major gene unlinked to the LDL receptor accounting for mild elevation in LDL cholesterol: The NHLBI Family Heart Study. Ann Hum Genet 63:401-412
10. Coon H, Leppert MF, Eckfeldt JH, Oberman A, Myers RH, Peacock JM, Province MA, Hopkins PN, Heiss G (1999) Genome-wide linkage analysis of lipids in the HyperGEN Blood Pressure Study. Arterioscler Thromb Vasc Biol. 21:1969-1976
11. David JA, Naito NK (1986) Separation of lipoprotein (Lp) fraction by the Beckman TL-100 table-top ultracentrifuge (UC). Clin Chem 32:1094
12. Dyke B (1996) PEDSYS: A Pedigree Data Management System, Version 2.0. Population genetics Laboratory, Southwest Foundation for Biomedical Research
13. Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, Utermann G, Moebius FF (1998) Mutations in the delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA 95:8181-8186
14. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
15. Friedlander Y, Kark JD (1987) Complex segregation analysis of plasma lipid and lipoprotein variables in a Jerusalem sample of nuclear families. Hum Hered 37:7-19
16. Gofman JW, Lingren F, Elliott H, Mantz W, Hewitt J (1950) The role of lipids and lipoproteins in atherosclerosis. Science 111:166-171
17. Goldstein JL, Hobbs HH, Brown MS (1995) Familial hypercholesterolemia. In: Scriver CR, Beaudet WSS, Valle D (eds) The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, pp. 1981-2030
18. Grundy SM (1992) Cholesterol-lowering drugs as cardioprotective agents. Am J Cardiol 70:271-321
19. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka M, Willaims R (1996) NHLBI Family Heart Study: Objectives and Design. Am J Epidemiol 143:1219-1228
20. Hinds D, Risch N (1999) The ASPEX Package: Affected Sib-Pair Exclusion Mapping v1.88. Available ftp://lahmed.stanford.edu/pub/aspex/doc/usage.html
21. Holmer L (1998) The human lamin B receptor/sterol reductase multigene family. Genomics 54:469-476
22. Illingworth DR (1990) Management of hyperlipidemia: Goals for the prevention of atherosclerosis. Clin Invest Med 13:211-218
23. Klos KL, Kardia SLR, Ferrell RE, Turner ST, Boerwinkle E, Sing CF (2001) Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol 21:971-978
24. Knoblauch H, Muller-Myhosok B, Busjahn A, Ben Avi L, Bahring S, Baron H, Heath SC, Uhlmann R, Faulhaber HD, Shpitzen S, Aydin A, Reshef A, Rosenthal M, Eliav O, Muhl A, Lowe A, Schurr D, Harats D, Jeschke E, Friedlander Y, Schuster H, Luft FC, Leitersdorf E (2000) A cholesterol-lowering gene maps to chromosome 13q. Am J Hum Genet 66:157-166
25. Kruglyak L, Lander ES (1995) Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet 57:439-454
26. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58:1347-1363
27. Lander E, Kruglyak (1995) Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
28. LaRosa JC, He J, Vupputuri S (1999) Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA 282:2340-2346
29. Lehto M, Laitinen S, Chinetti G, Johansson M, Ehnholm C, Staels B, Ikonen E, Olkkonen VM (2001) OSBP-related protein family in humans. J Lipid Res 42:1203-1213
30. Levannon D, Hsieh CL, Francke U, Dawson PA, Ridgway ND, Brown MS, Goldstein JL (1990) cDNA cloning of human oxysterol-binding protein and localization of the gene to human chromosome 11 and mouse chromosome 19. Genomics 7:65-74
31. Lewis CE, Arnett DK, Borecki I, Coon H, Ellison RC, Hunt S, Oberman A, Rich S, Province MA (1999) Genome-wide linkage analysis of human fatness: The HyperGEN blood pressure study. Am J Hum Genet 65:A1150
32. Lin J-P, Sholinsky P, Coon H, Hunt SC, Myers RH, Arnett DK, Hong Y (2001) Linkage between cholesterol 7alpha-hydroxylase (CYP7) gene and low-density lipoprotein cholesterol in increased CHD risk white families - The NHLBI Family Heart Study (Abstract). Am J Hum Genet 69:532
33. Linton MF, Farese RV Jr, Young SG (1993) Familial hypobetalipoproteinemia. J Lipid Res 34:521-541
34. Ludwig H, Hopkins PN, Allen A, Wu LL, Williams RR, Anderson LJ, Ward RH, Lalouel J-M, Innerarity TL (1997) Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J Lipid Res 38:1361-1373
35. Moebius FF, Fitzky BU, Lee JN, Paik Y-K, Glossmann H (1998) Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci USA 95:1899-1902
36. Morton NE, Gulbrandsen CL, Rhoads GG, Kagan A, Lew R (1978) Major loci for lipoprotein concentrations. Am J Hum Genet 30:583-589
37. Myant NB (1993) Familial defective apolipoprotein B-100: A review, including some comparisons with familial hypercholesterolemia. Atherosclerosis 104:1-18
38. Newman DL, McPeek MS, Abney M, Dytch H, Scanu AM, Parry R, Ober C (2000) Genome-wide screen for quantitative trait loci (QTLs) influencing lipid levels in a founder population (Abstract). Am J Hum Genet 67(Suppl 2):324
39. Pajukanta P, Terwilliger JD, Perola M, Hiekkalinna T, Nuotio I, Ellonen P, Parkkonen M, Hartiala J, Ylitalo K, Pihlajamaki J, Porkka K, Laakso M, Viikari J, Ehnholm C, Taskinen MR, Peltonen L (1999) Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet 64:1453-1463
40. Peacock JM, Arnett DK, Atwood LD, Myers RH, Province MA, Coon H, Rich SS, Heiss G (2001) Genome scan of quantitative trait loci linked to high density lipoproteincholesterol: The NHLBI Family Heart Study (FHS). Arterioscler Thromb Vasc Biol 21:1823-1828
41. Perusse L, Rice T, Despress JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C (1997) Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol 17:3263-3269
42. Rainwater DL, Almasy L, Blangero J, Cole SA, VandeBerg JL, MacCluer JW, Hixson JE (1999) A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol 19:777-783
43. Rice T, Vogler GP Laskarzewski PM, Rao DC (1991) Familial aggregation of lipids and lipoproteins in families ascertained through random and nonrandom probands in the Iowa Lipid Research Clinics Family Study. Hum Hered 41:107-121
44. Schectman G, Hiatt J (1996) Dose-response characteristics of cholesterol-lowering drug therapies: Implications for treatment. Ann Intern Med 125:990-1000
45. The Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389
46. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC (1998) Linkage between cholesterol 7α hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 101:1283-1291
47. Wassif CA, Maslen C, Kachilele-Linjewile S, Lin D, Linck LM, Connor WE, Steiner RD, Porter FD (1998) Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 63:55-62
48. Weber JL, Broman KW (2001) Genotyping for human whole-genome scans: Past, present, and future. Adv Genet 42:77-96
49. Williams RR, Hunt SC, Hopkins PN, Wu LL, Hasstedt SJ, Berry TD, Barlow GK, Stults BM, Schumacher MC, Ludwig EH, Elbein SC, Wilson DE, Lifton RP, Lalouel J-M (1993) Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 6:319S-327S